Information and Information Processing in Biological Systems Peter - - PowerPoint PPT Presentation

information and information processing in biological
SMART_READER_LITE
LIVE PREVIEW

Information and Information Processing in Biological Systems Peter - - PowerPoint PPT Presentation

Information and Information Processing in Biological Systems Peter Schuster, Ers Szathmry, and Avshalom Elitzur Institut fr Theoretische Chemie, Universitt Wien, Austria, Collegium Budapest Institute for Advanced Study , Ungarn, and


slide-1
SLIDE 1
slide-2
SLIDE 2

Information and Information Processing in Biological Systems

Peter Schuster, Eörs Szathmáry, and Avshalom Elitzur

Institut für Theoretische Chemie, Universität Wien, Austria, Collegium Budapest – Institute for Advanced Study , Ungarn, and Bar-Ilan University, Israel

Europäisches Forum Alpbach Alpbach, 18.– 25.08.2005

slide-3
SLIDE 3

Web-Pages for further information: http://www.tbi.univie.ac.at/~pks http://www.colbud.hu/fellows/szathmary.shtml http://faculty.biu.ac.il/~elitzua/

slide-4
SLIDE 4

Evolution Experiments in the Laboratory

Peter Schuster, Institut für Theoretische Chemie, Universität Wien

slide-5
SLIDE 5

Generation time Selection and adaptation 10 000 generations Genetic drift in small populations 106 generations Genetic drift in large populations 107 generations RNA molecules 10 sec 1 min 27.8 h = 1.16 d 6.94 d 115.7 d 1.90 a 3.17 a 19.01 a Bacteria 20 min 10 h 138.9 d 11.40 a 38.03 a 1 140 a 380 a 11 408 a Multicelluar organisms 10 d 20 a 274 a 20 000 a 27 380 a 2 × 107 a 273 800 a 2 × 108 a

Time scales of evolutionary change

slide-6
SLIDE 6

Bacterial Evolution

  • S. F. Elena, V. S. Cooper, R. E. Lenski. Punctuated evolution caused by selection of

rare beneficial mutants. Science 272 (1996), 1802-1804

  • D. Papadopoulos, D. Schneider, J. Meier-Eiss, W. Arber, R. E. Lenski, M. Blot.

Genomic evolution during a 10,000-generation experiment with bacteria. Proc.Natl.Acad.Sci.USA 96 (1999), 3807-3812

slide-7
SLIDE 7
slide-8
SLIDE 8

1 year

Epochal evolution of bacteria in serial transfer experiments under constant conditions

  • S. F. Elena, V. S. Cooper, R. E. Lenski. Punctuated evolution caused by selection of rare beneficial mutants.

Science 272 (1996), 1802-1804

slide-9
SLIDE 9

Variation of genotypes in a bacterial serial transfer experiment

  • D. Papadopoulos, D. Schneider, J. Meier-Eiss, W. Arber, R. E. Lenski, M. Blot. Genomic evolution during a

10,000-generation experiment with bacteria. Proc.Natl.Acad.Sci.USA 96 (1999), 3807-3812

slide-10
SLIDE 10

Evolutionary design of RNA molecules

D.B.Bartel, J.W.Szostak, In vitro selection of RNA molecules that bind specific ligands. Nature 346 (1990), 818-822 C.Tuerk, L.Gold, SELEX - Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase. Science 249 (1990), 505-510 D.P.Bartel, J.W.Szostak, Isolation of new ribozymes from a large pool of random sequences. Science 261 (1993), 1411-1418 R.D.Jenison, S.C.Gill, A.Pardi, B.Poliski, High-resolution molecular discrimination by RNA. Science 263 (1994), 1425-1429

  • Y. Wang, R.R.Rando, Specific binding of aminoglycoside antibiotics to RNA. Chemistry &

Biology 2 (1995), 281-290 Jiang, A. K. Suri, R. Fiala, D. J. Patel, Saccharide-RNA recognition in an aminoglycoside antibiotic-RNA aptamer complex. Chemistry & Biology 4 (1997), 35-50

slide-11
SLIDE 11

An example of ‘artificial selection’ with RNA molecules or ‘breeding’ of biomolecules

slide-12
SLIDE 12

The SELEX technique for the evolutionary preparation of aptamers

slide-13
SLIDE 13

additional methyl group

Dissociation constants and specificity of theophylline, caffeine, and related derivatives

  • f uric acid for binding to a discriminating

aptamer TCT8-4

slide-14
SLIDE 14

Secondary structures of aptamers binding theophyllin, caffeine, and related compounds

slide-15
SLIDE 15

Schematic drawing of the aptamer binding site for the theophylline molecule

slide-16
SLIDE 16

Aptamer binding to aminoglycosid antibiotics: Structure of ligands

  • Y. Wang, R.R.Rando, Specific binding of aminoglycoside antibiotics to RNA. Chemistry & Biology 2

(1995), 281-290

slide-17
SLIDE 17

tobramycin

A A A A A C C C C C C C C G G G G G G G G U U U U U U

5’- 3’-

A A A A A U U U U U U C C C C C C C C G G G G G G G G

5’-

  • 3’

RNA aptamer

Formation of secondary structure of the tobramycin binding RNA aptamer with KD = 9 nM

  • L. Jiang, A. K. Suri, R. Fiala, D. J. Patel, Saccharide-RNA recognition in an aminoglycoside antibiotic-

RNA aptamer complex. Chemistry & Biology 4:35-50 (1997)

slide-18
SLIDE 18

The three-dimensional structure of the tobramycin aptamer complex

  • L. Jiang, A. K. Suri, R. Fiala, D. J. Patel,

Chemistry & Biology 4:35-50 (1997)

slide-19
SLIDE 19

No new principle will declare itself from below a heap of facts.

Sir Peter Medawar, 1985

slide-20
SLIDE 20

RNA

RNA as scaffold for supramolecular complexes

ribosome ? ? ? ? ? RNA as transmitter of genetic information

DNA

...AGAGCGCCAGACUGAAGAUCUGGAGGUCCUGUGUUC...

messenger-RNA protein transcription translation RNA as

  • f genetic information

working copy

RNA is modified by epigenetic control RNA RNA editing Alternative splicing of messenger

Functions of RNA molecules

RNA is the catalytic subunit in supramolecular complexes

RNA as regulator of gene expression Gene silencing by small interfering RNAs Allosteric control of transcribed RNA

Riboswitches metabolites controlling transcription and translation through

The world as a precursor of the current + biology RNA DNA protein

RNA as catalyst Ribozyme RNA as adapter molecule

G A C . . . C U G . . .

leu genetic code

RNA as carrier of genetic information

RNA viruses and retroviruses RNA evolution in vitro Evolutionary biotechnology RNA aptamers, artificial ribozymes, allosteric ribozymes

slide-21
SLIDE 21

O CH2 OH O O P O O O

N1

O CH2 OH O P O O O

N2

O CH2 OH O P O O O

N3

O CH2 OH O P O O O

N4

N A U G C

k =

, , ,

3' - end 5' - end Na Na Na Na

5'-end 3’-end

GCGGAU AUUCGC UUA AGUUGGGA G CUGAAGA AGGUC UUCGAUC A ACCA GCUC GAGC CCAGA UCUGG CUGUG CACAG

Definition of RNA structure

slide-22
SLIDE 22

Examples of ‘natural selection’ with RNA molecules

slide-23
SLIDE 23

Genotype = Genome

GGCUAUCGUACGUUUACCCAAAAAGUCUACGUUGGACCCAGGCAUUGGAC.......G

Mutation Fitness in reproduction: Number of genotypes in the next generation Unfolding of the genotype: RNA structure formation Phenotype Selection

Evolution of phenotypes

slide-24
SLIDE 24

Genotype = Genome

GGCTATCGTACGTTTACCCAAAAAGTCTACGTTGGACCCAGGCATTGGAC.......G

Mutation Fitness in reproduction: Number of genotypes in the next generation Unfolding of the genotype: Development Phenotype Selection

Evolution of phenotypes

slide-25
SLIDE 25

Genotype = Genome

GGCTATCGTACGTTTACCCAAAAAGTCTACGTTGGACCCAGGCATTGGAC.......G

Mutation Fitness in reproduction: Number of genotypes in the next generation Unfolding of the genotype: Development Phenotype Selection

Evolution of phenotypes

slide-26
SLIDE 26

Stock Solution Reaction Mixture

Replication rate constant: fk = / [ + dS

(k)]

dS

(k) = dH(Sk,S)

Selection constraint: # RNA molecules is controlled by the flow N N t N ± ≈ ) ( The flowreactor as a device for studies of evolution in vitro and in silico

slide-27
SLIDE 27

f0 f f1 f2 f3 f4 f6 f5 f7

Replication rate constant: fk = / [ + dS

(k)]

dS

(k) = dH(Sk,S)

Evaluation of RNA secondary structures yields replication rate constants

slide-28
SLIDE 28

Phenylalanyl-tRNA as target structure Randomly chosen initial structure

slide-29
SLIDE 29

Formation of a quasispecies in sequence space

slide-30
SLIDE 30

Migration of a quasispecies through sequence space

slide-31
SLIDE 31

S{ = ( ) I{ f S

{ {

ƒ = ( )

S{ f{ I{

Mutation Genotype-Phenotype Mapping Evaluation of the Phenotype

Q{

j

I1 I2 I3 I4 I5 In

Q

f1 f2 f3 f4 f5 fn

I1 I2 I3 I4 I5 I{ In+1 f1 f2 f3 f4 f5 f{ fn+1

Q

Evolutionary dynamics including molecular phenotypes

slide-32
SLIDE 32

In silico optimization in the flow reactor: Trajectory (biologists‘ view) Time (arbitrary units) A v e r a g e d i s t a n c e f r

  • m

i n i t i a l s t r u c t u r e 5

  • d
  • S

500 750 1000 1250 250 50 40 30 20 10

Evolutionary trajectory

slide-33
SLIDE 33

In silico optimization in the flow reactor: Trajectory (physicists‘ view) Time (arbitrary units) A v e r a g e s t r u c t u r e d i s t a n c e t

  • t

a r g e t d

  • S

500 750 1000 1250 250 50 40 30 20 10

Evolutionary trajectory

slide-34
SLIDE 34

44

Average structure distance to target dS

  • Evolutionary trajectory

1250 10

44 42 40 38 36 Relay steps Number of relay step Time

Endconformation of optimization

slide-35
SLIDE 35

44 43

Average structure distance to target dS

  • Evolutionary trajectory

1250 10

44 42 40 38 36 Relay steps Number of relay step Time

Reconstruction of the last step 43 44

slide-36
SLIDE 36

44 43 42

Average structure distance to target dS

  • Evolutionary trajectory

1250 10

44 42 40 38 36 Relay steps Number of relay step Time

Reconstruction of last-but-one step 42 43 ( 44)

slide-37
SLIDE 37

44 43 42 41

Average structure distance to target dS

  • Evolutionary trajectory

1250 10

44 42 40 38 36 Relay steps Number of relay step Time

Reconstruction of step 41 42 ( 43 44)

slide-38
SLIDE 38

44 43 42 41 40

Average structure distance to target dS

  • Evolutionary trajectory

1250 10

44 42 40 38 36 Relay steps Number of relay step Time

Reconstruction of step 40 41 ( 42 43 44)

slide-39
SLIDE 39

44 43 42 41 40 39 Evolutionary process Reconstruction

Average structure distance to target dS

  • Evolutionary trajectory

1250 10

44 42 40 38 36 Relay steps Number of relay step Time

Reconstruction of the relay series

slide-40
SLIDE 40

Transition inducing point mutations Neutral point mutations

Change in RNA sequences during the final five relay steps 39 44

slide-41
SLIDE 41

In silico optimization in the flow reactor: Trajectory and relay steps Time (arbitrary units) A v e r a g e s t r u c t u r e d i s t a n c e t

  • t

a r g e t d

  • S

500 750 1000 1250 250 50 40 30 20 10

Evolutionary trajectory

Relay steps

slide-42
SLIDE 42

In silico optimization in the flow reactor: Main transitions Main transitions Relay steps Time (arbitrary units) Average structure distance to target d S

500 750 1000 1250 250 50 40 30 20 10

Evolutionary trajectory

slide-43
SLIDE 43

00 09 31 44

Three important steps in the formation of the tRNA clover leaf from a randomly chosen initial structure corresponding to three main transitions.

slide-44
SLIDE 44

AUGC GC Movies of optimization trajectories over the AUGC and the GC alphabet

slide-45
SLIDE 45

RNA sequence RNA structure

  • f minimal free

energy

RNA folding: Structural biology, spectroscopy of biomolecules, understanding molecular function Empirical parameters Biophysical chemistry: thermodynamics and kinetics

Sequence, structure, and design

slide-46
SLIDE 46

RNA sequence RNA structure

  • f minimal free

energy

RNA folding: Structural biology, spectroscopy of biomolecules, understanding molecular function Inverse Folding Algorithm Iterative determination

  • f a sequence for the

given secondary structure

Sequence, structure, and design

Inverse folding of RNA: Biotechnology, design of biomolecules with predefined structures and functions

slide-47
SLIDE 47

Minimum free energy criterion

Inverse folding of RNA secondary structures

1st 2nd 3rd trial 4th 5th

The inverse folding algorithm searches for sequences that form a given RNA secondary structure under the minimum free energy criterion.

slide-48
SLIDE 48

A multi-component neutral network formed by a rare structure: < cr

slide-49
SLIDE 49

A connected neutral network formed by a common structure: > cr

slide-50
SLIDE 50

Neighborhood in sequence space and the degree of neutrality

slide-51
SLIDE 51

Gk Neutral Network

Structure S

k

Gk C

  • k

Compatible Set Ck

The compatible set Ck of a structure Sk consists of all sequences which form Sk as its minimum free energy structure (the neutral network Gk) or one of its suboptimal structures.

slide-52
SLIDE 52

Structure S Structure S

1

The intersection of two compatible sets is always non empty: C0 C1

slide-53
SLIDE 53

„...Variations neither useful not injurious would not be affected by natural selection, and would be left either a fluctuating element, as perhaps we see in certain polymorphic species, or would ultimately become fixed, owing to the nature of the

  • rganism and the nature of the conditions.

...“

Charles Darwin, Origin of species (1859)

slide-54
SLIDE 54

Motoo Kimura’s Population genetics of neutral evolution. Evolutionary rate at the molecular level. Nature 217: 624-626, 1955. The Neutral Theory of Molecular Evolution. Cambridge University Press. Cambridge, UK, 1983.

slide-55
SLIDE 55
slide-56
SLIDE 56

Mount Fuji

Example of a smooth landscape on Earth

slide-57
SLIDE 57

Dolomites Bryce Canyon

Examples of rugged landscapes on Earth

slide-58
SLIDE 58

Genotype Space Fitness

Start of Walk End of Walk

Evolutionary optimization in absence of neutral paths in sequence space

slide-59
SLIDE 59

Genotype Space F i t n e s s

Start of Walk End of Walk Random Drift Periods Adaptive Periods

Evolutionary optimization including neutral paths in sequence space

slide-60
SLIDE 60

Grand Canyon

Example of a landscape on Earth with ‘neutral’ ridges and plateaus

slide-61
SLIDE 61
slide-62
SLIDE 62
slide-63
SLIDE 63

RNA 9:1456-1463, 2003

Evidence for neutral networks and shape space covering

slide-64
SLIDE 64

Evidence for neutral networks and intersection of apatamer functions

slide-65
SLIDE 65

Nature , 323-325, 1999 402

Catalytic activity in the AUG alphabet

slide-66
SLIDE 66

O O O O H H H H H H H H H N N N N N N N N N O O H N N H O N N N N N N N

G=U (U=A) A=U U=G

O N

Base pairs in the AUG alphabet

slide-67
SLIDE 67

Nature , 841-844, 2002 420

Catalytic activity in the DU alphabet

slide-68
SLIDE 68

2 2 6 5 6 8 C ’

1

C ’

1

5 4 4 4 2 9 7 6 3 3 2 1 1

The 2,6-diamino purine – uracil, DU, base pair

slide-69
SLIDE 69

A ribozyme switch

E.A.Schultes, D.B.Bartel, Science 289 (2000), 448-452

slide-70
SLIDE 70

Two ribozymes of chain lengths n = 88 nucleotides: An artificial ligase (A) and a natural cleavage ribozyme of hepatitis--virus (B)

slide-71
SLIDE 71

The sequence at the intersection: An RNA molecules which is 88 nucleotides long and can form both structures

slide-72
SLIDE 72

Two neutral walks through sequence space with conservation of structure and catalytic activity

slide-73
SLIDE 73

GGCUAUCGUACGUUUACCCAAAAAGUCUACGUUGGACCCAGGCAUUGGACG

Better be afraid I can ‚karate‘

slide-74
SLIDE 74